中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 42 Issue 5
May  2026
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2026  >  42(5): 1236-1240

Value of ultrasound in assessing microvascular invasion of intrahepatic cholangiocarcinoma and related technical advances

DOI: 10.12449/JCH260535

  • Department of Ultrasound，The Affiliated Hospital of Inner Mongolia Medical University，Hohhot 010050，China

Research funding:

Inner Mongolia Medical University General Project (YKD2025MS006)

More Information
  • Corresponding author: LI Haochang， haochangli0606@sina.com （ORCID： 0009-0009-1197-4912）
  • Received Date: 2025-08-17
  • Accepted Date: 2025-11-03
  • Published Date: 2026-05-25
    Abstract
  • Noninvasive preoperative assessment of microvascular invasion （MVI） of intrahepatic cholangiocarcinoma （ICC） is crucial for developing individualized treatment regimens and judging the prognosis of patients. This article comprehensively explores the application value of ultrasound in this field and elaborates on the performance of techniques such as gray-scale ultrasound， contrast-enhanced ultrasound， and ultrasound elastography in predicting MVI by analyzing lesion morphology， blood perfusion， and stiffness characteristics， and meanwhile， it also discusses the application prospects of emerging techniques such as radiomics， deep learning， and dynamic three-dimensional contrast-enhanced ultrasound. The comprehensive analysis shows that ultrasound has an important clinical value in assessing ICC MVI， and the integration of emerging techniques into the ultrasound evaluation system can help to achieve more objective and accurate preoperative prediction and thus has broad application prospects.

     

    • FullText(HTML)
  • loading
    • References(37)
  • [1]
    National Health Commission of the People’s Republic of China. Standard for diagnosis and treatment of primary liver cancer(2024 edition)[J]. J Clin Hepatol, 2024, 40( 5): 893- 918. DOI: 10.12449/JCH240508.

    中华人民共和国国家卫生健康委员会. 原发性肝癌诊疗指南(2024年版)[J]. 临床肝胆病杂志, 2024, 40( 5): 893- 918. DOI: 10.12449/JCH240508.
    [2]
    TJADEN C, HINZ U, KLAIBER U, et al. Distal bile duct cancer: Radical(R0> 1 mm) resection achieves favorable survival[J]. Ann Surg, 2023, 277( 1): e112- e118. DOI: 10.1097/SLA.0000000000005012.
    [3]
    DING ZW, ZHAO YM, WANG L. Progress in surgical and systematic treatment of intrahepatic cholangiocarcinoma[J/OL]. Chin J Hepat Surg(Electronic Edition), 2025, 14( 2): 187- 196. DOI: 10.3877/cma.j.issn.2095-3232.2025033.

    丁志文, 赵一鸣, 王鲁. 肝内胆管癌手术与综合治疗[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14( 2): 187- 196. DOI: 10.3877/cma.j.issn.2095-3232.2025033.
    [4]
    CHOI WJ, WILLIAMS PJ, CLAASEN MPAW, et al. Systematic review and meta-analysis of prognostic factors for early recurrence in intrahepatic cholangiocarcinoma after curative-intent resection[J]. Ann Surg Oncol, 2022, 29: 4337- 4353. DOI: 10.1245/s10434-022-11463-x.
    [5]
    GOUW ASH, BALABAUD C, KUSANO H, et al. Markers for microvascular invasion in hepatocellular carcinoma: Where do we stand[J]. Liver Transpl, 2011, 17( Suppl 2): S72- S80. DOI: 10.1002/lt.22368.
    [6]
    ZHANG XP, WANG K, WEI XB, et al. An eastern hepatobiliary surgery hospital microvascular invasion scoring system in predicting prognosis of patients with hepatocellular carcinoma and microvascular invasion after R0 liver resection: A large-scale, multicenter study[J]. Oncologist, 2019, 24( 12): e1476- e1488. DOI: 10.1634/theoncologist.2018-0868.
    [7]
    OLIVEIRA IS, KILCOYNE A, EVERETT JM, et al. Cholangiocarcinoma: Classification, diagnosis, staging, imaging features, and management[J]. Abdom Radiol(NY), 2017, 42( 6): 1637- 1649. DOI: 10.1007/s00261-017-1094-7.
    [8]
    SPOLVERATO G, EJAZ A, KIM Y, et al. Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2014, 18( 7): 1284- 1291. DOI: 10.1007/s11605-014-2533-1.
    [9]
    ZHOU Y, WANG XL, XU C, et al. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion[J]. J Magn Reson Imaging, 2019, 50( 1): 315- 324. DOI: 10.1002/jmri.26566.
    [10]
    CHEN S, WAN LJ, ZHAO R, et al. Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma[J]. Abdom Radiol(NY), 2024, 49( 2): 425- 436. DOI: 10.1007/s00261-023-04079-6.
    [11]
    GUO JY, WANG MB, XUE SY, et al. Establishment a nomogram model for preoperative prediction of the risk of cholangiocarcinoma with microvascular invasion[J]. Eur J Surg Oncol, 2025, 51( 1): 109361. DOI: 10.1016/j.ejso.2024.109361.
    [12]
    CAI CP, WANG XJ, FU QR, et al. The VEGF expression associated with prognosis in patients with intrahepatic cholangiocarcinoma: A systematic review and meta-analysis[J]. World J Surg Oncol, 2022, 20( 1): 40. DOI: 10.1186/s12957-022-02511-7.
    [13]
    YUAN MX, LI R, ZHANG YJ, et al. Enhancement patterns of intrahepatic cholangiocarcinoma on contrast-enhanced ultrasound: Correlation with clinicopathologic findings and prognosis[J]. Ultrasound Med Biol, 2019, 45( 1): 26- 34. DOI: 10.1016/j.ultrasmedbio.2018.08.014.
    [14]
    JANG HJ, KIM DH, CHOI SH, et al. Preoperative prediction of microvascular invasion in intrahepatic cholangiocarcinoma and its prognostic implications: A multicenter study[J]. Liver Cancer, 2025. DOI: 10.1159/000547071.[ Epub ahead of print]
    [15]
    MA XJ, LIU LH, FANG J, et al. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma[J]. Cancer Imaging, 2020, 20( 1): 40. DOI: 10.1186/s40644-020-00318-x.
    [16]
    SALEH M, VIRARKAR M, BURA V, et al. Intrahepatic cholangiocarcinoma: Pathogenesis, current staging, and radiological findings[J]. Abdom Radiol(NY), 2020, 45( 11): 3662- 3680. DOI: 10.1007/s00261-020-02559-7.
    [17]
    GUO HL, ZHENG X, CHENG MQ, et al. Contrast-enhanced ultrasound for differentiation between poorly differentiated hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. J Ultrasound Med, 2022, 41( 5): 1213- 1225. DOI: 10.1002/jum.15812.
    [18]
    AINORA ME, CERRITO L, LIGUORI A, et al. Multiparametric dynamic ultrasound approach for differential diagnosis of primary liver tumors[J]. Int J Mol Sci, 2023, 24( 10): 8548. DOI: 10.3390/ijms24108548.
    [19]
    WANG XH, LIANG P, YU J, et al. Contrast-enhanced ultrasound features predict the prognosis of percutaneous microwave ablation of intrahepatic cholangiocarcinoma[J]. Br J Radiol, 2022, 95( 1133): 20211379. DOI: 10.1259/bjr.20211379.
    [20]
    SIRICA AE, GORES GJ. Desmoplastic stroma and cholangiocarcinoma: Clinical implications and therapeutic targeting[J]. Hepatology, 2014, 59( 6): 2397- 2402. DOI: 10.1002/hep.26762.
    [21]
    ALISON MR. Liver stem cells: Implications for hepatocarcinogenesis[J]. Stem Cell Rev, 2005, 1( 3): 253- 260. DOI: 10.1385/SCR: 1: 3: 253.
    [22]
    ZHU MR, ZHAO CK, SUN YK, et al. Subtype prediction of intrahepatic cholangiocarcinoma using dynamic contrast-enhanced ultrasound[J]. Insights Imaging, 2024, 15( 1): 119. DOI: 10.1186/s13244-024-01683-y.
    [23]
    AFFO S, YU LX, SCHWABE RF. The role of cancer-associated fibroblasts and fibrosis in liver cancer[J]. Annu Rev Pathol, 2017, 12: 153- 186. DOI: 10.1146/annurev-pathol-052016-100322.
    [24]
    PISCAGLIA F, SALVATORE V, MULAZZANI L, et al. Ultrasound shear wave elastography for liver disease. a critical appraisal of the many actors on the stage[J]. Ultraschall Med, 2016, 37( 1): 1- 5. DOI: 10.1055/s-0035-1567037.
    [25]
    CARPINO G, OVERI D, MELANDRO F, et al. Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure[J]. Clin Proteomics, 2019, 16: 37. DOI: 10.1186/s12014-019-9257-x.
    [26]
    XU CC, JIANG D, TAN BB, et al. Preoperative diagnosis and prediction of microvascular invasion in hepatocellularcarcinoma by ultrasound elastography[J]. BMC Med Imaging, 2022, 22( 1): 88. DOI: 10.1186/s12880-022-00819-0.
    [27]
    TIAN QY, YU J, HUANG G. Pathogenesis of hepatitis B-associated intrahepatic cholangiocarcinoma[J]. J Clin Hepatol, 2024, 40( 4): 797- 803. DOI: 10.12449/JCH240425.

    田奇玉, 余建, 黄罡. 乙型肝炎相关肝内胆管癌的发病机制[J]. 临床肝胆病杂志, 2024, 40( 4): 797- 803. DOI: 10.12449/JCH240425.
    [28]
    SHI ML, SHEN Y, WANG MD, et al. Interpretation of clinical practice guidelines of diagnosis and treatment of hepatobiliary tumors: hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. Chin J Dig Surg, 2024, 23( 2): 188- 196. DOI: 10.3760/cma.j.cn115610-20231212-00251.

    石明亮, 申洋, 王明达, 等. 肝胆肿瘤临床诊疗实践系列指南解读: 肝细胞癌和肝内胆管癌[J]. 中华消化外科杂志, 2024, 23( 2): 188- 196. DOI: 10.3760/cma.j.cn115610-20231212-00251.
    [29]
    MASSARWEH NN, EL-SERAG HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. Cancer Control, 2017, 24( 3): 1073274817729245. DOI: 10.1177/1073274817729245.
    [30]
    ZHONG X, CHEN LL, LONG HY, et al. The"stiff rim" sign of hepatocellular carcinoma on shear wave elastography: Correlation with pathological features and potential prognostic value[J]. Abdom Radiol(NY), 2022, 47( 12): 4115- 4125. DOI: 10.1007/s00261-022-03628-9.
    [31]
    MA JM, SUN L, LI XM, et al. Research progress of radiomics inpredicting microvascular invasion of intrahepatic cholangicarcinoma[J]. Chin J Magn Reson Imag, 2024, 15( 12): 224- 227, 234. DOI: 10.12015/issn.1674-8034.2024.12.035.

    马佳美, 孙柳, 李晓萌, 等. 影像组学预测肝内胆管癌微血管侵犯的研究进展[J]. 磁共振成像, 2024, 15( 12): 224- 227, 234. DOI: 10.12015/issn.1674-8034.2024.12.035.
    [32]
    XU L, CHEN ZA, ZHU D, et al. The application status of radiomics-based machine learning in intrahepatic cholangiocarcinoma: Systematic review and meta-analysis[J]. J Med Internet Res, 2025, 27: e69906. DOI: 10.2196/69906.
    [33]
    PENG YT, ZHOU CY, LIN P, et al. Preoperative ultrasound radiomics signatures for noninvasive evaluation of biological characteristics of intrahepatic cholangiocarcinoma[J]. Acad Radiol, 2020, 27( 6): 785- 797. DOI: 10.1016/j.acra.2019.07.029.
    [34]
    HU HT, WANG Z, HUANG XW, et al. Ultrasound-based radiomics score: A potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma[J]. Eur Radiol, 2019, 29( 6): 2890- 2901. DOI: 10.1007/s00330-018-5797-0.
    [35]
    MAO LJ, CAO JY, WANG WP, et al. Application of dynamic three-dimensional contrast-enhanced ultrasound in the diagnosis of focal liver lesions[J]. Fudan Univ J Med Sci, 2021, 48( 5): 598- 602. DOI: 10.3969/j.issn.1672-8467.2021.05.005.

    毛丽娟, 曹佳颖, 王文平, 等. 动态三维超声造影在肝局灶性病变诊断中的应用[J]. 复旦学报(医学版), 2021, 48( 5): 598- 602. DOI: 10.3969/j.issn.1672-8467.2021.05.005.
    [36]
    SONG Y, CHENG JL, ZHANG RF. Contribution of 3-dimensional contrast-enhanced ultrasonography(CEUS) compared with 2-dimensional CEUS in the analysis of liver tumors[J]. J Ultrasound Med, 2018, 37( 5): 1117- 1128. DOI: 10.1002/jum.14458.
    [37]
    CAO JY, YU LY, LIN C, et al. Dynamic three-dimensional contrast-enhanced ultrasonography for local minimally invasive treatment assessment on a rabbit hepatic VX2 tumor model[J]. Chin J Ultrasound Med, 2019, 35( 11): 1034- 1037.

    曹佳颖, 于凌云, 林冲, 等. 动态三维超声造影评估兔肝VX2肿瘤局部微创治疗效果的实验研究[J]. 中国超声医学杂志, 2019, 35( 11): 1034- 1037.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (24) PDF downloads(9) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return